Graves disease in men
Pro Research Analysisby 
Searched over 200M research papers
Graves' Disease in Men: Epidemiology, Clinical Features, and Management
Epidemiology of Graves' Disease in Men
Graves' disease, an autoimmune disorder leading to hyperthyroidism, is less common in men compared to women, affecting approximately 0.5% of men during their lifetime Burch2015Vejražková2018. Despite its lower prevalence, the disease often presents more severely in men, with a higher incidence of Graves' orbitopathy and relapse rates . Studies have shown that men with Graves' disease tend to have a larger goiter and a higher rate of vision loss compared to women .
Clinical Features and Severity
Men with Graves' disease often experience more severe symptoms and complications. Graves' orbitopathy, a condition characterized by inflammation and swelling of the eye muscles and tissues, is more severe in men, with a higher likelihood of vision impairment Diédhiou2018Wiersinga2002. The disease's natural history shows that while mild forms may remit spontaneously, severe forms require more aggressive treatment . Additionally, men are more likely to experience a relapse of hyperthyroidism after initial treatment Diédhiou2018Vejražková2018.
Genetic Factors and Recurrence
Genetic predisposition plays a significant role in the development and recurrence of Graves' disease. Studies indicate that familial forms of the disease suggest a strong genetic component, with certain human leukocyte antigen (HLA) variants being potential predictors of disease development and recurrence . This genetic predisposition underscores the importance of personalized treatment plans and monitoring for men with a family history of Graves' disease.
Management and Treatment Options
The management of Graves' disease in men involves several treatment options, including antithyroid drugs, radioactive iodine (RAI), and surgery. The choice of treatment depends on various factors such as patient preference, clinical features, and potential side effects .
- Antithyroid Drugs: These are often the first line of treatment and can lead to remission in about 50% of patients after a 12- to 18-month course. However, they carry risks of adverse reactions like agranulocytosis and hepatotoxicity, particularly within the first 90 days of therapy .
- Radioactive Iodine (RAI): This treatment is effective but can exacerbate thyroid eye disease in 15-20% of patients. It is often recommended for patients who do not respond to antithyroid drugs or have contraindications to surgery Burch2015Wiersinga2002.
- Surgery: Near-total thyroidectomy is preferred in cases with large goiters, severe thyroid eye disease, or when malignancy is suspected. While effective, surgery carries risks such as hypoparathyroidism and vocal cord paralysis .
Conclusion
Graves' disease in men, though less common than in women, presents with more severe clinical features and a higher relapse rate. Understanding the genetic predispositions and tailoring treatment plans to individual needs are crucial for effective management. Physicians must weigh the benefits and risks of each treatment option to provide optimal care for male patients with Graves' disease.
Sources and full results
Most relevant research papers on this topic